Skip to main content
Top
Literature
1.
go back to reference Snow H, Davies E, Strauss DC, Smith M, Hayes AJ. Conservative re-excision is a safe and simple alternative to radical resection in revision surgery for dermatofibrosarcoma protuberans. Ann Surg Oncol. 2019 (in press). Snow H, Davies E, Strauss DC, Smith M, Hayes AJ. Conservative re-excision is a safe and simple alternative to radical resection in revision surgery for dermatofibrosarcoma protuberans. Ann Surg Oncol. 2019 (in press).
2.
go back to reference Foroozan M, Sei JF, Amini M, Beauchet A, Saiag P. Efficacy of Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: systematic review. Arch Dermatol. 2012;148(9):1055–1063.CrossRef Foroozan M, Sei JF, Amini M, Beauchet A, Saiag P. Efficacy of Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans: systematic review. Arch Dermatol. 2012;148(9):1055–1063.CrossRef
3.
go back to reference Fiore M, Miceli R, Mussi C, Lo Vullo S, Mariani L, Lozza L, et al. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol. 2005;23(30):7669–7675.CrossRef Fiore M, Miceli R, Mussi C, Lo Vullo S, Mariani L, Lozza L, et al. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol. 2005;23(30):7669–7675.CrossRef
4.
go back to reference Huis In ‘t Veld EA, van Coevorden F, Grunhagen DJ, Smith MJ, van Akkooi ACJ, Wouters M, et al. Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated? Cancer. 2019;125(5):735–741.CrossRef Huis In ‘t Veld EA, van Coevorden F, Grunhagen DJ, Smith MJ, van Akkooi ACJ, Wouters M, et al. Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated? Cancer. 2019;125(5):735–741.CrossRef
5.
go back to reference Decanter G, Stoeckle E, Honore C, Meeus P, Mattei JC, Dubray-Longeras P, et al. Watch and wait approach for re-excision after unplanned yet macroscopically complete excision of extremity and superficial truncal soft tissue sarcoma is safe and does not affect metastatic risk or amputation rate. Ann Surg Oncol. 2019;26(11):3526–3534.CrossRef Decanter G, Stoeckle E, Honore C, Meeus P, Mattei JC, Dubray-Longeras P, et al. Watch and wait approach for re-excision after unplanned yet macroscopically complete excision of extremity and superficial truncal soft tissue sarcoma is safe and does not affect metastatic risk or amputation rate. Ann Surg Oncol. 2019;26(11):3526–3534.CrossRef
Metadata
Title
Margins in DFSP Reconsidered: Primum Non Nocere
Author
Winan J. van Houdt
Publication date
01-03-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 3/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-08012-4

Other articles of this Issue 3/2020

Annals of Surgical Oncology 3/2020 Go to the issue